-
Mashup Score: 29Temporal trends in antifungal susceptibility of Cryptococcus neoformans isolates from a reference laboratory in the United States, 2011–2021 - 2 month(s) ago
Background There are no established clinical breakpoints for antifungal agents against Cryptococcus species; however, epidemiological cut-off values can help distinguish wild-type (WT) isolates with…
Source: onlinelibrary.wiley.comCategories: General Medicine News, Infectious DiseaseTweet
-
Mashup Score: 26
We provide a description of cryptococcal infections following SARS-CoV-2 infection describing predisposing factors, symptoms, disease manifestations, and mortal
Source: academic.oup.comCategories: General Medicine News, Infectious DiseaseTweet-
#ScholarlySunday features Dr. @EloyOrdayaMD who contributed to the largest multicenter series of cases of cryptococcosis after COVID-19. Congratulations Eloy and to your MSG-19 collaborators. @PascalisID @CIDJournal https://t.co/Af0kszdmgI https://t.co/W4hVbRmh3O
-
-
Mashup Score: 42Left Ventricular Assist Device: Review of Antimicrobial Prophylaxis Strategies and Incidence of Infections at a Tertiary Care Center 12-Year Experience - 4 month(s) ago
AbstractBackground. Left ventricular assist devices (LVAD) have an associated infection rate of 13%–80% postimplant. An optimal strategy for surgical infection
Source: academic.oup.comCategories: General Medicine News, Infectious DiseaseTweet-
#ScholarlySunday features the collaborative work of our fellows Drs. @MariAleMendozaD , @NischalR3 and @dr_bisono on LVAD implantation prophylaxis. Congratulations to our productive team and mentors!!! @IDdocAdi https://t.co/NHFDLUXCfW https://t.co/pqSiLhyIeV
-
-
Mashup Score: 4Clinical characteristics and outcomes of pancreatic fungal infection in patients with necrotizing pancreatitis - 6 month(s) ago
Abstract. Pancreatic fungal infection (PFI) in patients with necrotizing pancreatitis can lead to significant morbidity and mortality. The incidence of PFI has
Source: academic.oup.comCategories: Infectious Disease, Latest HeadlinesTweet-
#ScholarlySunday features the research work of our fellows, Drs. @S_Chesdachai and @ZYetmar (who have graduated) during their #MayoIDFellowship. In this paper, they describe fungal infections in patients with necrotizing pancreatitis. https://t.co/Z0oXkwWVHE https://t.co/EQ3DaWMRZ5
-
-
Mashup Score: 0
To describe the incidence, epidemiology, and outcomes of vascular graft infection (VGI) in a population-based study in southern Minnesota.Retrospectiv…
Source: www.sciencedirect.comCategories: Infectious Disease, Latest HeadlinesTweet-
#ScholarlySunday features the work of #MayoIDFellowship graduates, Drs. @HussamTabaja and @S_Chesdachai , on a population-based study of vascular graft infections in southern Minnesota. Congratulations Hussam and Mac! @LBaddour1 https://t.co/l8q7Wp5dyw https://t.co/PaAliMQJX9
-
-
Mashup Score: 0Therapeutics for Clostridioides difficile infection: molecules and microbes - PubMed - 6 month(s) ago
Metronidazole is no longer advised for management of outpatient CDI. The preferred medication of choice for a first episode is oral vancomycin or fidaxomicin. For those patients who recur after the first episode, vancomycin taper pulse or fidaxomicin can be used. Intravenous bezlotoxumab, a monoclon …
Source: pubmed.ncbi.nlm.nih.govCategories: Gastroenterology, Latest HeadlinesTweet-
#ScholarlySunday-This review focuses on therapeutics of CDI and includes sections on primary prevention, management of active infection, and prevention of recurrent CDI. @EliVothMD @khanna_S https://t.co/Vb9MPLJaBW
-
-
Mashup Score: 11Candidemia in Patients With Cardiovascular Implantable Electronic Devices: Uncertainty in Management Based on Current International Guidelines - 8 month(s) ago
We investigated the risk of CIED infection after candidemia. The study found that 17% of patients were confirmed to have CIED infection, whereas the status of C
Source: academic.oup.comCategories: Infectious Disease, Latest HeadlinesTweet-
#ScholarlySunday features the work of recent #MayoIDFellowship graduates (and now on Mayo Clinic faculty) Drs. @S_Chesdachai and @HussamTabaja and the CVID team on the risk of CIED infections in patients with candidemia. Read their findings here: https://t.co/Mu1JhoN5i6 https://t.co/T2aV48E9cy
-
-
Mashup Score: 2Effect of endoscopic sleeve gastroplasty on gastric emptying, motility and hormones: a comparative prospective study - PubMed - 9 month(s) ago
NCT03406975.
Source: pubmed.ncbi.nlm.nih.govCategories: Gastroenterology, Latest HeadlinesTweet-
#ScholarlySunday-Prospective study shows ESG produces weight loss with favorable changes in gastrointestinal physiology while preserving gastric motility and function. @EricJVargasMD @babudayyeh @Gut_BMJ https://t.co/38mMRjAK0r
-
-
Mashup Score: 0
In this phase 2b trial, treatment with pegozafermin led to improvements in fibrosis. These results support the advancement of pegozafermin into phase 3 development. (Funded by 89bio; ENLIVEN ClinicalTrials.gov number, NCT04929483.).
Source: PubMedCategories: Gastroenterology, Latest HeadlinesTweet-
#ScholarlySunday-This phase 2b trial, Tx w/pegozafermin, a long-acting FGF21 analogue, led to improved liver fibrosis w/i 24 wks in pts w/biopsy-proven NASH supporting advmt of pegozafermin to phase 3 development https://t.co/enZ1HXD1og https://t.co/xJjGBFiXpl
-
-
Mashup Score: 0CS-iCCA, A New Clinically Based Staging System for Intrahepatic Cholangiocarcinoma: Establishment and External Validation - PubMed - 9 month(s) ago
The proposed independently validated staging system uses nonhistopathologic data to successfully stratify patients into 4 stages. This staging system has better prognostic accuracy compared with the TNM staging and can assist physicians and patients in treatment of iCCA.
Source: PubMedCategories: Gastroenterology, Latest HeadlinesTweet-
#ScholarlySunday-We developed Clinical Staging for Intrahepatic Cholangiocarcinoma (CS-iCCA) based on clinical parameters assessed at Dx to improve our ability to predict pt outcomes to select pt groups w/similar outcomes to include in clinical trials. https://t.co/g0KgbcMvgF
-
#ScholarlySunday features the work of Dr. @EloyOrdayaMD, our third year fellow under the Transplant ID Track. Here, he examined the trends in antifungal susceptibility of Cryptococcus neoformans isolates. @pascalisID @MadihaFidaMD @omarabusaleh15 https://t.co/g3QMLo4XUn https://t.co/B2AySblqGl